Form 4: Cardinal Health CFO Sells Over 48,000 Shares

Cardinal Health's Chief Financial Officer, Aaron E. Alt, reported the sale of over 48,000 common shares following the vesting of equity awards.

Summary

• Aaron E. Alt, Chief Financial Officer of Cardinal Health Inc. (CAH), reported multiple transactions involving the company's common shares.
• On August 15, 2025, 11,363 common shares were acquired through a grant of restricted share units (RSUs) at a price of $0, with vesting scheduled in three equal annual installments beginning August 15, 2026.
• On August 15, 2025, 34,866 common shares were disposed of at $150.22 to satisfy tax withholding obligations related to the vesting of 10,288 RSUs and 67,448 performance share units.
• On August 19, 2025, 34,455 common shares were sold at a weighted average price of $148.61, with prices ranging from $148.00 to $148.99.
• On August 19, 2025, an additional 13,788 common shares were sold at a weighted average price of $149.19, with prices ranging from $149.00 to $149.58.
• Following these transactions, beneficial ownership of common shares by Aaron E. Alt stands at 30,650 shares.

Sentiment

Score: 3

Explanation: The sentiment is moderately negative due to the significant insider selling by a key executive (CFO). While some shares were acquired via RSU grant, the subsequent sales and tax withholdings on vested awards indicate a reduction in direct beneficial ownership, which can be perceived as a lack of confidence or a move to diversify holdings.

Positives

• The Chief Financial Officer received a grant of 11,363 restricted share units (RSUs) as part of compensation, aligning executive incentives with long-term company performance.

Negatives

• The Chief Financial Officer sold a total of 48,243 common shares (34,455 shares at $148.61 and 13,788 shares at $149.19) in open market transactions.
• A significant number of shares (34,866) were withheld to cover tax obligations related to the vesting of equity awards, indicating a substantial portion of vested shares were not retained.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders may interpret the significant insider selling by the Chief Financial Officer as a negative signal regarding the company's near-term prospects or valuation.
• The transactions reflect the executive's compensation structure, including equity awards and their subsequent tax implications.

Next Steps

• The granted restricted share units (RSUs) will vest in three equal annual installments beginning on August 15, 2026.

Key Dates

Recommendation

The significant insider selling by the Chief Financial Officer, while potentially for personal financial planning, can be viewed negatively by the market. However, without additional context on company performance or broader market trends, a 'hold' recommendation is prudent. Investors should monitor future insider activity and company fundamentals for a clearer picture.

Keywords

Cardinal Health, CAH, Insider Trading, Form 4, Stock Sale, CFO, Restricted Share Units, Equity Compensation